title: Protocol for the treatment of radiation injuries.
abstract: Despite adequate precautionary measures and high-quality safeguard devices, many accidental radiation exposures continue to occur and may pose greater risks in the future, including radiation exposure in the space environment.  The medical management of radiation casualties is of major concern to health care providers.  Such medical management was addressed at The First Consensus Development Conference on the Treatment of Radiation Injuries, Washington, DC, 1989.  The conference addressed the most appropriate treatment for the hematopoietic and infectious complications that accompany radiation injuries and for combined radiation and traumatic/burn injuries.  Based on the evidence presented at the conference, a consensus statement was formulated by expert physicians and scientists.  The recommended therapies, including a suggested algorithm incorporating these recommendations for the treatment of radiation injuries, will be discussed.
authors.affiliation: Medical Radiobiology Advisory Team, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889-5245, USA.
authors.forename: D
authors.initials: D
authors.lastname: Browne
authors.forename: J F
authors.initials: JF
authors.lastname: Weiss
authors.forename: T J
authors.initials: TJ
authors.lastname: MacVittie
authors.forename: M V
authors.initials: MV
authors.lastname: Pillai
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000379:methods; D002056:Burns / Q000628:therapy; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006413:Hematopoietic System / Q000503:physiopathology / Q000528:radiation effects; D006801:Humans; D009104:Multiple Trauma / Q000628:therapy; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000145:classification / Q000601:surgery / Q000628:therapy*; D018788:Radioactive Hazard Release; D013026:Space Flight; D014218:Triage; D014947:Wounds and Injuries / Q000628:therapy*
chemical_list: D000900:Anti-Bacterial Agents; D016298:Hematopoietic Cell Growth Factors